From slacktivism to activism: Improving the commitment power of e-pledges for prosocial causes

por Chou, Eileen Y., Hsu, Dennis Y., Hernon, Eileen
Publicado 2020

In silico modeling of combination systemic therapy for advanced renal cell carcinoma

por Kotecha, Ritesh R, Hsu, Dennis J, Lee, Chung-Han, Patil, Sujata, Voss, Martin H
Publicado 2021

Wish-making during the COVID-19 pandemic enhances positive appraisals and job satisfaction

por Ng, Thomas W.H., Hsu, Dennis Y., Yim, Frederick H.K., Zou, Yinuo, Chen, Haoyang
Publicado 2021

A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein

por Carver, Joseph, Dexheimer, Thomas S., Hsu, Dennis, Weng, Meng-Tzu, Smith, Jordan L., Guha, Rajarshi, Jadhav, Ajit, Simeonov, Anton, Luo, Ji
Publicado 2014

A Meta-Analysis to Assess the Efficacy of HER2-Targeted Treatment Regimens in HER2-Positive Metastatic Colorectal Cancer (mCRC)

por Chitkara, Akshit, Bakhtiar, Muhammad, Sahin, Ibrahim Halil, Hsu, Dennis, Zhang, Janie, Anamika, FNU, Mahnoor, Mahnoor, Ahmed, Rabeea, Gholami, Sepideh, Saeed, Anwaar
Publicado 2023

Arginine limitation causes a directed DNA sequence evolution response in colorectal cancer cells

por Hsu, Dennis J., Gao, Jenny, Yamaguchi, Norihiro, Pinzaru, Alexandra, Mandayam, Nandan, Liberti, Maria, Heissel, Søren, Alwaseem, Hanan, Tavazoie, Saeed, Tavazoie, Sohail F.
Publicado 2023

Arginine limitation drives a directed codon-dependent DNA sequence evolution response in colorectal cancer cells

por Hsu, Dennis J., Gao, Jenny, Yamaguchi, Norihiro, Pinzaru, Alexandra, Wu, Qiushuang, Mandayam, Nandan, Liberti, Maria, Heissel, Søren, Alwaseem, Hanan, Tavazoie, Saeed, Tavazoie, Sohail F.
Publicado 2023

Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance

por Cheng, Han-Ying, Hsieh, Chia-Hsin, Lin, Po-Han, Chen, Yu-Tung, Hsu, Dennis Shin-Shian, Tai, Shyh-Kuan, Chu, Pen-Yuan, Yang, Muh-Hwa
Publicado 2022

A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer

por Chung, Shin-Yi, Chang, Yu-Chan, Hsu, Dennis Shin-Shian, Hung, Ya-Chi, Lu, Meng-Lun, Hung, Yi-Ping, Chiang, Nai-Jung, Yeh, Chun-Nan, Hsiao, Michael, Soong, John, Su, Yeu, Chen, Ming-Huang
Publicado 2022

Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway

por Chung, Shin-Yi, Hung, Yi-Ping, Pan, Yi-Ru, Chang, Yu-Chan, Wu, Chiao-En, Hsu, Dennis Shin-Shian, Chang, Peter Mu-Hsin, Lu, Meng-Lun, Huang, Chi-Ying F., Su, Yeu, Hsiao, Michael, Yeh, Chun-Nan, Chen, Ming-Huang
Publicado 2021

Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients

por Yeh, Chun-Nan, Chang, Yu-Chan, Su, Yeu, Shin-Shian Hsu, Dennis, Cheng, Chi-Tung, Wu, Ren-Chin, Chung, Yi-Hsiu, Chiang, Kun-Chun, Yeh, Ta-Sen, Lu, Meng-Lun, Liu, Chun-Yu, Mu-Hsin Chang, Peter, Chen, Ming-Han, Huang, Chi-Ying F., Hsiao, Michael, Chen, Ming-Huang
Publicado 2017

PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy

por Tan, Kien Thiam, Yeh, Chun-Nan, Chang, Yu-Chan, Cheng, Jen-Hao, Fang, Wen-Liang, Yeh, Yi-Chen, Wang, Yu-Chao, Hsu, Dennis Shin-Shian, Wu, Chiao-En, Lai, Jiun-I, Chang, Peter Mu-Hsin, Chen, Ming-Han, Lu, Meng-Lun, Chen, Shu-Jen, Chao, Yee, Hsiao, Michael, Chen, Ming-Huang
Publicado 2020